1. Home
  2. BMR vs BCDA Comparison

BMR vs BCDA Comparison

Compare BMR & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beamr Imaging Ltd.

BMR

Beamr Imaging Ltd.

N/A

Current Price

$1.09

Market Cap

17.8M

Sector

Technology

ML Signal

N/A

Logo BioCardia Inc.

BCDA

BioCardia Inc.

N/A

Current Price

$0.92

Market Cap

15.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BMR
BCDA
Founded
2009
N/A
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.8M
15.7M
IPO Year
2021
2009

Fundamental Metrics

Financial Performance
Metric
BMR
BCDA
Price
$1.09
$0.92
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $15.50
AVG Volume (30 Days)
74.7K
★ 116.9K
Earning Date
08-11-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $479,000.00
Revenue This Year
$0.19
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.06
$0.75
52 Week High
$2.51
$1.80

Technical Indicators

Market Signals
Indicator
BMR
BCDA
Relative Strength Index (RSI) 31.70 44.40
Support Level N/A $0.82
Resistance Level $1.40 $1.28
Average True Range (ATR) 0.10 0.08
MACD -0.06 -0.00
Stochastic Oscillator 1.44 28.14

Price Performance

Historical Comparison
BMR
BCDA

About BMR Beamr Imaging Ltd.

Beamr Imaging Ltd provides content-adaptive video compression solutions for human viewing and machine vision. The company is trusted by technology companies such as NVIDIA and Amazon Web Services, and serves media companies including Netflix, Paramount, and JioHotstar. Using Emmy-winning patented technology, its solutions help deliver media content with high quality while reducing storage and delivery costs. Its customers include over-the-top content distributors, video streaming platforms, and Hollywood studios that use its products to store, distribute, and monetize video and images across devices. The company operates in the United States, Israel, and the rest of the world, with the United States generating maximum revenue.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: